E-Cigarette Flavors for Tobacco Addiction
(TEN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether certain e-cigarette flavors increase addiction by affecting brain function and behavior. Researchers focus on two specific flavors to determine their impact on nicotine use. The trial seeks regular users of inhaled tobacco products who do not plan to quit soon. Participants must read and write in English and use the provided e-cigarette device for at least three hours daily. As an unphased trial, this study allows participants to contribute to groundbreaking research on the impact of e-cigarette flavors.
Will I have to stop taking my current medications?
If you are currently using smoking cessation medications like varenicline or nicotine patches, you will need to stop taking them to participate in this trial. The protocol does not specify other medications, so it's best to discuss your specific situation with the trial coordinators.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that flavoring agents in e-cigarette liquids, such as hexyl acetate, can cause health issues, including inflammation, cell damage, and DNA stress. These reactions suggest the body might respond negatively to these chemicals. However, specific information on serious side effects or their frequency remains unavailable.
The treatments tested in this study are not new drugs but different e-cigarette flavors. This trial examines how these flavors affect brain function and behavior. As an exploratory trial, it focuses on understanding the impact of these flavors rather than their safety.
When considering participation, note that hexyl acetate and ethyl acetate are already present in some e-cigarette products. This suggests the risk of serious side effects might be low, but the evidence is not definitive. Always weigh the potential risks and benefits before deciding.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for tobacco addiction because they explore the impact of e-cigarette flavors, like hexyl acetate and ethyl acetate, on quitting smoking. Unlike traditional nicotine replacement therapies or medications that focus solely on delivering nicotine, these treatments investigate how specific flavors might influence smoking behavior and reduce cravings. The potential to make quitting smoking more appealing and accessible by leveraging enjoyable flavors could offer a new dimension to smoking cessation strategies, making it a promising area of study.
What evidence suggests that this trial's treatments could be effective for tobacco addiction?
This trial will compare the effects of different e-cigarette flavors on tobacco addiction. Research has shown that flavors in e-cigarettes, such as hexyl acetate, can increase their appeal and assist people in quitting smoking. In this trial, one group will receive e-cigarettes with hexyl acetate, while another group will receive e-cigarettes with ethyl acetate. Studies indicate that flavors can alter brain function and influence behavior, potentially making e-cigarettes more attractive than regular cigarettes. Hexyl acetate is popular among users, which could encourage continued use and support smoking cessation. Additionally, flavors in e-liquids can affect brain function, possibly influencing addiction habits. Overall, these findings suggest that flavored e-cigarettes may help people reduce or quit smoking.16789
Are You a Good Fit for This Trial?
This trial is for adults over 21 who regularly use tobacco products like vapes, cigarettes, or cigars and have done so for the last three months. Participants should not be planning to quit tobacco within the next month and must be able to read and write in English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use ENDS with either a neuroactive flavor (hexyl acetate) or an inactive flavor (ethyl acetate) for ten days
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Flavor
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator